TY - JOUR
T1 - Genetic Insights on the Relation of Vascular Risk Factors and Cervical Artery Dissection
AU - CADISP Consortium
AU - Le Grand, Quentin
AU - Ecker Ferreira, Leslie
AU - Metso, Tiina M.
AU - Schilling, Sabrina
AU - Tatlisumak, Turgut
AU - Grond-Ginsbach, Caspar
AU - Engelter, Stefan T.
AU - Lyrer, Philippe
AU - Majersik, Jennifer J.
AU - Worrall, Bradford B.
AU - Southerland, Andrew M.
AU - Markus, Hugh S.
AU - Lathrop, Mark
AU - Thijs, Vincent
AU - Leys, Didier
AU - Amouyel, Philippe
AU - Dallongeville, Jean
AU - Dichgans, Martin
AU - Pezzini, Alessandro
AU - Bersano, Anna
AU - Sargurupremraj, Muralidharan
AU - Debette, Stéphanie
N1 - Publisher Copyright:
© 2023 American College of Cardiology Foundation
PY - 2023/10/3
Y1 - 2023/10/3
N2 - Background: The association between vascular risk factors and cervical artery dissections (CeADs), a leading cause of ischemic stroke (IS) in the young, remains controversial. Objectives: This study aimed to explore the causal relation of vascular risk factors with CeAD risk and recurrence and compare it to their relation with non-CeAD IS. Methods: This study used 2-sample Mendelian randomization analyses to explore the association of blood pressure (BP), lipid levels, type 2 diabetes, waist-to-hip ratio, smoking, and body mass index with CeAD and non-CeAD IS. To simulate effects of the most frequently used BP-lowering drugs, this study constructed genetic proxies and tested their association with CeAD and non-CeAD IS. In analyses among patients with CeAD, the investigators studied the association between weighted genetic risk scores of vascular risk factors and the risk of multiple or early recurrent dissections. Results: Genetically determined higher systolic BP (OR: 1.51; 95% CI: 1.32-1.72) and diastolic BP (OR: 2.40; 95% CI: 1.92-3.00) increased the risk of CeAD (P < 0.0001). Genetically determined higher body mass index was inconsistently associated with a lower risk of CeAD. Genetic proxies for β-blocker effects were associated with a lower risk of CeAD (OR: 0.65; 95% CI: 0.50-0.85), whereas calcium-channel blockers were associated with a lower risk of non-CeAD IS (OR: 0.75; 95% CI: 0.63-0.90). Weighted genetic risk scores for systolic BP and diastolic BP were associated with an increased risk of multiple or early recurrent CeAD. Conclusions: These results are supportive of a causal association between higher BP and increased CeAD risk and recurrence and provide genetic evidence for lower CeAD risk under β-blockers. This may inform secondary prevention strategies and trial design for CeAD.
AB - Background: The association between vascular risk factors and cervical artery dissections (CeADs), a leading cause of ischemic stroke (IS) in the young, remains controversial. Objectives: This study aimed to explore the causal relation of vascular risk factors with CeAD risk and recurrence and compare it to their relation with non-CeAD IS. Methods: This study used 2-sample Mendelian randomization analyses to explore the association of blood pressure (BP), lipid levels, type 2 diabetes, waist-to-hip ratio, smoking, and body mass index with CeAD and non-CeAD IS. To simulate effects of the most frequently used BP-lowering drugs, this study constructed genetic proxies and tested their association with CeAD and non-CeAD IS. In analyses among patients with CeAD, the investigators studied the association between weighted genetic risk scores of vascular risk factors and the risk of multiple or early recurrent dissections. Results: Genetically determined higher systolic BP (OR: 1.51; 95% CI: 1.32-1.72) and diastolic BP (OR: 2.40; 95% CI: 1.92-3.00) increased the risk of CeAD (P < 0.0001). Genetically determined higher body mass index was inconsistently associated with a lower risk of CeAD. Genetic proxies for β-blocker effects were associated with a lower risk of CeAD (OR: 0.65; 95% CI: 0.50-0.85), whereas calcium-channel blockers were associated with a lower risk of non-CeAD IS (OR: 0.75; 95% CI: 0.63-0.90). Weighted genetic risk scores for systolic BP and diastolic BP were associated with an increased risk of multiple or early recurrent CeAD. Conclusions: These results are supportive of a causal association between higher BP and increased CeAD risk and recurrence and provide genetic evidence for lower CeAD risk under β-blockers. This may inform secondary prevention strategies and trial design for CeAD.
KW - Mendelian randomization
KW - blood pressure
KW - cervical artery dissection
KW - drug effect
KW - ischemic stroke
KW - young adults
UR - http://www.scopus.com/inward/record.url?scp=85171132680&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85171132680&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2023.07.021
DO - 10.1016/j.jacc.2023.07.021
M3 - Article
C2 - 37758436
AN - SCOPUS:85171132680
SN - 0735-1097
VL - 82
SP - 1411
EP - 1423
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 14
ER -